Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications?

por Samara, P., Ioannou, K., Tsitsilonis, O.E.
Publicado 2016

Clonal evolution is a prognostic factor for the clinical progression of monoclonal B-cell lymphocytosis

por Kostopoulos, I V, Paterakis, G, Pavlidis, D, Kastritis, E, Terpos, E, Tsitsilonis, O E, Papadhimitriou, S I
Publicado 2017

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2

por Gavalas, N G, Tsiatas, M, Tsitsilonis, O, Politi, E, Ioannou, K, Ziogas, A C, Rodolakis, A, Vlahos, G, Thomakos, N, Haidopoulos, D, Terpos, E, Antsaklis, A, Dimopoulos, M A, Bamias, A
Publicado 2012

B06 HIGH LEVELS OF CIRCULATING PLASMA CELLS AT DIAGNOSIS ARE PREDICTIVE FOR WORSE PROGNOSIS IN BOTH TRANSPLANT-ELIGIBLE AND -INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA

por Malandrakis, P., Ntanasis-Stathopoulos, I., Kostopoulos, I.V., Roussakis, P., Eleutherakis-Papaiakovou, E., Panteli, C., Angelis, N., Spiliopoulou, V., Orologas-Stavrou, N., Theodorakakou, F., Fotiou, D., Migkou, M., Gavriatopoulou, M., Kastritis, E., Tsitsilonis, O.E., Dimopoulos, M.A., Terpos, E.
Publicado 2023